Clinical Trial Update: A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of faldaprevir, ribavirin, and TD-6450 for hepatitis C virus infection has completed, reporting results from…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Faldaprevir (faldaprevir)
• Ribavirin (ribavirin)
• TD-6450 (TD-6450)

Snippet

Sponsor: Trek Therapeutics, PBC | Conditions: Hepatitis C Viral Infection, Chronic Hepatitis C | Phase 2 | Status: COMPLETED